• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Profiling levels of cognitive functioning at 6 months following traumatic brain injury

byRhianna DavisandAlex Chan
December 30, 2023
in Chronic Disease, Neurology, Psychiatry
Reading Time: 2 mins read
Share on FacebookShare on Twitter

1. Many participants who sustained a traumatic brain injury experienced no cognitive dysfunction, though more severe initial injuries were associated with a greater risk of cognitive decline 6 months of follow-up. 

Evidence Rating Level: 1 (Excellent)

Traumatic Brain Injuries (TBIs) are often associated with cognitive dysfunction. The typical course of cognitive recovery during the first several months following the experience of a TBI has not previously been well established. In this prospective cohort study, researchers collected data from Transforming Research and Clinical Knowledge in TBI (TRACK-TBI). Participants included 1057 individuals over age 17 who presented to Level I trauma centers in the United States within 24 hours of sustaining a head injury between March 2014 and July 2018. Participants were categorized as having sustained an msTBI (GCS score 3-12) or mTBI (GCS score 13-15). Cognitive function was assessed 6 months after the initial TBI via performance on standard neuropsychological tests. Participants were compared to control subjects who presented to the same centers after sustaining orthopedic injuries, as well as uninjured friends and family members. 6-months following the initial injury, the majority of participants demonstrated cognitive functioning within 1.5 standard deviations compared to the control group, 49.3% of the msTBI group (95% CI, 39.5%-59.2%) and 67.5% of the mTBI group (95% CI, 63.7%-71.2%) showed no evidence of impairment. Among the individuals who experienced cognitive impairments at 6 months, effects were observed across domains of memory, processing speed, and executive functioning. A limitation of this study is that only patients who presented to Level I trauma centers were included, and as such, the data may not be generalizable to other populations who sustain a TBI. Strengths of this study include the large cohort size and the prospective study design. Overall, this study demonstrates that at 6 months following a TBI, many participants experienced no cognitive dysfunction, though a higher proportion of individuals with impairment sustained more severe initial injuries.

Click to read the study in JAMA Network Open

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Older married couples demonstrate domain-specific cognitive concordance 

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Tags: cognitioncognitive neurologyneurologyneuropsychiatryneurosurgerypsychiatrytrauma
Previous Post

Certain genetic predispositions may increase risk of atrial fibrillation among those with high alcohol consumption

Next Post

Tafamidis attenuates the decline of cardiac function in patients with transthyretin amyloid cardiomyopathy

RelatedReports

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Neurology

Older married couples demonstrate domain-specific cognitive concordance 

August 28, 2026
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Quick Take: Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children
Chronic Disease

Positive psychotherapy may be similarly effective to traditional cognitive behavioural therapy for panic disorder

August 21, 2026
Next Post
Patisiran therapy reduces ventricular myocardial strain in hereditary transthyretin amyloidosis

Tafamidis attenuates the decline of cardiac function in patients with transthyretin amyloid cardiomyopathy

Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use

Rates of opioid agonist therapy initiation increasing after hospital visits for opioid toxicity in Ontario, Canada

American Academy of Pediatrics recommends standards for adverse event disclosures

2 Minute Medicine Rewind January 1, 2024

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer
  • The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low
  • Azacitidine–venetoclax improved event-free survival in induction-eligible AML
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in